US Stocks
/
Bicara Therapeutics Inc. Share Price
Bicara Therapeutics Inc. Share Price

Bicara Therapeutics Inc. Share Price

NASDAQ: BCAX | Mega Cap
$17.50
+$0.25 (1.48%) Last updated on 10 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Bicara Therapeutics Inc. Stock Performance

Open
$17.19
Prev. Close
$17.25
Circuit Range
N/A
Day Range
$17.04 - $17.82
Year Range
$13.79 - $30.93
Volume
52,076
Average Traded
$17.53

Bicara Therapeutics Inc. Share Price Today

As of 12 October 2026, Bicara Therapeutics Inc.'s share price is $17.50. The stock opened at $17.19, compared to its previous close of $17.25. During today's trading session, Bicara Therapeutics Inc.'s share price traded between $17.04 and $17.82, with an average price of $17.43. Over the past 52 weeks, the stock has recorded a high of $30.93 and a low of $13.79. In terms of performance, Bicara Therapeutics Inc.'s share price has declined by 19.09% over the last six months and is up 7.73% on a year-on-year basis.

Bicara Therapeutics Inc. Share Price Chart

$17.04$17.82
L
Show Current Price
H

Bicara Therapeutics Inc. Stock Fundamentals & Key Indicators

Market Cap
$956.85B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.80
Revenue (TTM)
$0.00
Return On Equity (TTM)
-39.54%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-52.60%

Bicara Therapeutics Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$36.33-$37.39-$56.21-$55.44
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-2.92%-50.33%1.37%

Bicara Therapeutics Inc. Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$68.00-$137.95
Net Profit MarginN/AN/A
Income ChangeN/A-102.87%

About Bicara Therapeutics Inc.

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. The company's goal is to build a fully integrated, commercial-stage biopharmaceutical company that develops important therapies for people living with cancer, starting with ficerafusp alfa.

Bicara Therapeutics Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$19.05
$17.53
-5.95%
Sep 2026
$22.73
$18.64
-24.90%
Aug 2026
$26.24
$24.82
-8.41%
Jul 2026
$29.55
$27.10
-8.69%
Jun 2026
$21.02
$29.68
+36.52%
May 2026
$21.57
$21.74
+0.51%
Apr 2026
$20.14
$21.63
+8.83%
Mar 2026
$16.43
$19.88
+18.30%
Feb 2026
$17.00
$16.80
+0.00%
Jan 2026
$16.50
$16.80
-0.12%
Dec 2025
$17.82
$16.82
-9.28%
Nov 2025
$15.87
$18.54
+14.13%

BCAX Share Price FAQs

What is Bicara Therapeutics Inc. share price today?

chevron-up
Bicara Therapeutics Inc. share price today is $17.50 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Bicara Therapeutics Inc. stock?

chevron-up
The 52 week high of Bicara Therapeutics Inc. stock is $30.93, while the 52 week low is $13.79 as of 10 Oct '26.

What is BCAX's market capitalisation today?

chevron-up
BCAX market capitalisation is $956.85B as of October 12, 2026, at 2:08 am IST.

What is BCAX's net income for the last quarter?

chevron-up
BCAX's net income for the last quarter is -55.44B USD.

What is the 5 year returns of BCAX?

chevron-up
The 5 year returns of BCAX is -31.08% as on 10 Oct '26.

What is the high & low stock price of BCAX today?

chevron-up
BCAX stock price hit a high of $17.82 and low of $17.04 as of 10 Oct '26.

Can I buy BCAX shares in India?

chevron-up
Yes. You can buy BCAX in India by opening an international trading account.